Valeurs seuils pour le rapport coût-efficacité en soins de santé - KCE

66 ICER Thresholds KCE Reports 100
102. Williams A. Is the QALY a technical solution to a political problem? Of course not! Int J Health
Serv. 1991;21(2):365-9; discussion 71-2.
103. Baltussen R, ten Asbroek AH, Koolman X, Shrestha N, Bhattarai P, Niessen LW. Priority
setting using multiple criteria: should a lung health programme be implemented in Nepal?
Health Policy Plan. 2007;22(3):178-85.
104. Mitton C, Donaldson C. Health care priority setting: principles, practice and challenges. Cost
Eff Resour Alloc. 2004;2(1):3.
105. Gibson J, Mitton C, Martin D, Donaldson C, Singer P. Ethics and economics: does programme
budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy.
2006;11(1):32-7.
106. Nord E, Richardson J, Street A, Kuhse H, Singer P. Maximizing health benefits vs egalitarianism:
an Australian survey of health issues. Soc Sci Med. 1995;41(10):1429-37.
107. Dolan P, Cookson R. A qualitative study of the extent to which health gain matters when
choosing between groups of patients. Health Policy. 2000;51(1):19-30.
108. Klevit HD, Bates AC, Castanares T, Kirk EP, Sipes-Metzler PR, Wopat R. Prioritization of
health care services. A progress report by the Oregon Health Services Commission. Arch
Intern Med. 1991;151(5):912-6.
109. Allen D, Lee RH, Lowson K. The use of QALYS (quality-adjusted life years) in health service
planning. Int J Health Plann Manage. 1989;4(4):261-73.
110. Eddy DM. Oregon's methods. Did cost-effectiveness analysis fail? JAMA. 1991;266(15):2135-41.
111. Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, et al. Use of
pharmacoeconomics information--report of the ISPOR Task Force on use of
pharmacoeconomic/health economic information in health-care decision making. Value Health.
2003;6(4):407-16.
112. Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluation studies on
decision making. A European survey. The EUROMET group. Health Policy. 2000;52(3):179-92.
113. Williams A. QALYS and ethics: a health economist's perspective. Soc Sci Med.
1996;43(12):1795-804.
114. Grosse SD, Teutsch SM, Haddix AC. Lessons from cost-effectiveness research for United
States public health policy. Annu Rev Public Health. 2007;28:365-91.
115. Williams I, Bryan S, McIver S. How should cost-effectiveness analysis be used in health
technology coverage decisions? Evidence from the National Institute for Health and Clinical
Excellence approach. J Health Serv Res Policy. 2007;12(2):73-9.
116. Simon HA. Administrative Behaviour: A Study of Decision making Processes in Administrative
Organizations. 3rd ed. New York: Free Press; 1976.
117. March JG, Olsen JP. Organizational learning and the ambiguity of the past. . In: March JG, Olsen
JP, editors. Ambiguity and Choice in Organizations. 2nd ed. Bergen, Norway:
118.
Universitatsforlaget; 1987.
Lindblom CE. The Science of Muddling Through. Public Administration Review. 1959;19(2):79-
88.
119. Elliott H, Popay J. How are policy makers using evidence? Models of research utilisation and
local NHS policy making. J Epidemiol Community Health. 2000;54(6):461-8.
120. Davis P, Howden-Chapman P. Translating research findings into health policy. Soc Sci Med.
1996;43(5):865-72.
121. Kothari A, Birch S, Charles C. "Interaction" and research utilisation in health policies and
programs: does it work? Health Policy. 2005;71(1):117-25.
122. Innvaer S, Vist G, Trommald M, Oxman A. Health policy-makers' perceptions of their use of
evidence: a systematic review. J Health Serv Res Policy. 2002;7(4):239-44.
123. Lavis JN, Lomas J, Hamid M, Sewankambo NK. Assessing country-level efforts to link research
to action. Bull World Health Organ. 2006;84(8):620-8.
124. Milewa T, Barry C. Health Policy and the Politics of Evidence. Social Policy and Administration.
2005;39(5):498-512.
125. Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B. Use of cost-effectiveness analysis in
health-care resource allocation decision making: how are cost-effectiveness thresholds
expected to emerge? Value Health. 2004;7(5):518-28.